The performance of paracanoists is characterized by the ability of the athlete to advance at maximum speed, through a technically optimal paddling motion. It`s important to consider that in the case of para-athletes, the application of forces towards paddling is compromised by physical deficiencies. Thus, this study aims to assess the performance of athletes in the KL1, KL2 and KL3 sport classes, during a paralympic paracanoe event. The sample was composed of athletes from the Brazilian male paracanoe team, with a representative of each sport class: KL1, KL2, KL3 For performance analysis, we used a kayak ergometer (KayakPro®, Miami Beach, FL, USA) to simulate a 200-meter trial, during Rio 2016 Paralympic Games Road. The variables were evaluated: time trial, stroke frequency, mean speed, number of strokes, stroke length, stroke index, and power. According to results: I) the athlete KL3 had the lowest number of strokes, the longest stroke length and the highest stroke rate index; II) the athlete KL1 had the highest number of strokes, the lowest stroke length and the stroke rate index. This study puts into perspective the distinct characteristics of a paracanoe trial, analyzed in consideration to each sport class.
Resumo O estudo tem por objetivo investigar as implicações da especialização precoce em atletas de GAF (Ginástica Artística Feminina). A partir de uma pesquisa bibliográfica caracterizamos essa primeira etapa da especialização, e apresentamos as discutições relativas ao treinamento na fase da infância/adolescência (8-12 anos de idade). Em seguida relacionamos esses tópicos à especificidade da GAF, procurando entender as particularidades da modalidade durante essa etapa.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.